Skip to main content
. 2020 Jun 25;12(6):1692. doi: 10.3390/cancers12061692

Table 5.

CfmiRs that are commonly DE in MBM-01 and MBM-02 plasma samples compared to normal donors’ samples not present in the MBM tissues.

Probe FC MBM-01
vs. Normal
Adjusted
p-Value
FC MBM-02
vs. Normal
Adjusted
p-Value
miR-6741-3p 6.46 7.65 × 10−37 3.02 6.24 × 10−15
miR-6852-3p 5.34 2.41 × 10−22 4.9 7.63 × 10−26
miR-4689 4.14 1.21 × 10−27 6.84 4.66 × 10−41
miR-3943 3.56 6.57 × 10−21 3.01 2.44 × 10−21
miR-541-3p 3.34 8.31 × 10−18 1.56 7.64 × 10−4
miR-3157-5p 3.12 2.07 × 10−17 3.27 1.08 × 10−24
miR-4784 2.44 1.27 × 10−13 1.73 3.33 × 10−7
miR-4279 2.36 2.28 × 10−9 1.79 5.84 × 10−6
miR-4664-3p 2.17 1.96 × 10−10 4.31 7.29 × 10−24
miR-4291 1.93 1.26 × 10−5 2.63 2.68 × 10−19
miR-3912-5p 1.88 7.34 × 10−7 1.71 1.14 × 10−7
miR-5694 1.82 2.47 × 10−4 1.46 6.00 × 10−3
miR-3912-3p 1.79 1.35 × 10−5 1.57 4.39 × 10−5
miR-670-3p 1.78 3.53 × 10−5 2.66 3.32 × 10−22
miR-4665-5p 1.68 2.79 × 10−4 5.89 2.77 × 10−23
miR-3937 1.67 1.10 × 10−3 2.98 3.76 × 10−8

DE = differentially expressed. CfmiRs = cell-free microRNAs. MBM-01 = melanoma brain metastasis first cohort. MBM-02 = melanoma brain metastasis second cohort. MBM = Melanoma brain metastasis. FC = fold-change.